Home LiteratureArticle Details
PMID: 1394133 Published · ppublish English Comparative Study Journal Article Research Support, Non-U.S. Gov't

p53 mutations in breast cancer.

Cancer research ·Vol. 52 ·No. 19 ·1992-10-01 ·Pages 5291-8

Coles C, Condie A, Chetty U, Steel CM, Evans HJ, Prosser J

Abstract

We have identified and analyzed 41 mutations in p53 in sporadic breast tumors from 136 unselected breast cancer patients and estimate that approximately 40% of such tumors contain p53 mutations. The frequency of G-T transversions and the incidence of guanosine mutations in the nontranscribed strand of the p53 gene were found to be higher than expected, and we suggest, therefore, that exogenous carcinogens have an etiological role in sporadic breast cancers. Mutations were recorded in 44 codons of the p53 gene, with no obvious mutational hot-spots, although mutations at codons 175, 194, 273, and 280 accounted for 25% of the changes. One germ-line mutation was found in 136 patients and so we conclude that constitutional mutation of p53 may be an uncommon etiological factor in breast cancer.

Related Genes
p53
MeSH Terms
Base Composition Breast Neoplasms/genetics Chromosomes, Human, Pair 17/physiology Codon/genetics Colonic Neoplasms/genetics Female Genes, p53/genetics Heterozygote Humans Incidence Li-Fraumeni Syndrome/genetics Mutation
Chemicals
Codon
Authors & Affiliations
6 authors, click to expand affiliations / ORCID
Coles C
MRC Human Genetics Unit, Western General Hospital, Edinburgh, Scotland.
Condie A
Chetty U
Steel C M
Evans H J
Prosser J
Article Info
Journal
Cancer research
Abbr.
Cancer Res
ISSN
0008-5472
Published
1992-10-01
Pages
5291-8
Language
English
Region
United States
NLM ID
2984705R
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com